Skip to content
Search

Latest Stories

'Community pharmacies at risk of layoffs and service reductions without funding boost', says NPA

'Community pharmacies at risk of layoffs and service reductions without funding boost', says NPA

Suggests a 2.5 per cent of the NHS budget to restore community pharmacy funding 

The National Pharmacy Association (NPA) has raised concerns over the upcoming increase in the National Living Wage, saying it will make things even worse for local pharmacies already facing nearly a decade of cuts in real terms.


Scheduled to go up from £10.42 to £11.44 per hour starting April, the National Living Wage rise is expected to put a lot of financial pressure on many pharmacies.

The NPA says "it will cost them over £10,000 in salary bills, and for some, even more, without getting more from the NHS funds. and has asked the government to deal with the ongoing problem of underfunding for community pharmacies.

The association has warned that without additional funds, pharmacies could face staff layoffs or reduced services to cover the increased wages, calling for a "comprehensive new funding deal to prevent further closures of vital local services, which have been shutting at the rate of eight a week."

Paul Rees, the NPA's chief executive, emphasised the urgent need for a revamped funding arrangement that enables pharmacies to invest in their workforce and sustain essential services thereby averting further closures as up to three quarters of pharmacies are in experiencing losses.

Rees said, "the current pharmacy contract in England has tied us into years of flat funding, whilst costs have risen relentlessly, including wages. We need to restore community pharmacy funding to 2.5% of the NHS budget - the historical norm – to keep vital services going. "

Echoing Rees's sentiments, Olivier Picard, NPA's vice-chair and owner of Newdays Pharmacy in Buckinghamshire, warned of potential repercussions, including increased closures and diminished services, unless accompanied by a corresponding rise in NHS funding.

"Dedicated pharmacy staff deserve a decent wage, but this increase represents yet another hike in costs for a sector which has lost more than £1.3bn in real terms over the past decade," he said.

Picard further highlighted the wage increase as yet another financial burden for a sector already dealing with the effects of significant losses over the past decade and added that "each new, unfunded cost makes pharmacies more unsustainable."

The National Living Wage, which started in 2016, sets the lowest hourly pay for people over 23 years old. But from April, even 21-year-olds will be able to get it for the first time, and younger workers will also see their pay go up a bit.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less